# Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid

> **NCT00469131** · PHASE3 · COMPLETED · sponsor: **Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan** · enrollment: 79 (actual)

## Conditions studied

- Hepatitis C
- Liver Cirrhosis

## Interventions

- **DRUG:** tacrolimus + steroid
- **DRUG:** tacrolimus + mycophenolate mofetil

## Key facts

- **NCT ID:** NCT00469131
- **Lead sponsor:** Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** 2010-08
- **Final completion:** 2011-08
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2011-09-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00469131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00469131, "Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00469131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*